TY  - JOUR
AU  - Calina, Daniela
AU  - Hernandez, Antonio F
AU  - Hartung, Thomas
AU  - Egorov, Alexey M
AU  - Izotov, Boris Nikolaevich
AU  - Nikolouzakis, Taxiarchis Konstantinos
AU  - Tsatsakis, Aristidis
AU  - Vlachoyiannopoulos, Panayiotis G
AU  - Docea, Anca Oana
PY  - 2021
DO  - 10.3390/life11090907
SN  - 2075-1729
UR  - http://hdl.handle.net/10668/18569
T2  - Life (Basel, Switzerland)
AB  - In the context of the current COVID-19 pandemic, traditional, complex and lengthy methods of vaccine development and production would not have been able to ensure proper management of this global public health crisis. Hence, a number of technologies...
LA  - en
PB  - MDPI AG
KW  - COVID-19 pandemic
KW  - coronaviruses
KW  - mRNA vaccines
KW  - public health
KW  - side effects
KW  - Humans
KW  - COVID-19 Vaccines
KW  - mRNA Vaccines
KW  - Public Health
KW  - COVID-19
KW  - RNA, Messenger
KW  - Pandemics
KW  - Vaccines
KW  - Communicable Diseases
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - Iatrogenic Disease
KW  - Technology
KW  - Workforce
TI  - Challenges and Scientific Prospects of the Newest Generation of mRNA-Based Vaccines against SARS-CoV-2.
TY  - research article
VL  - 11
ER  -